Cheryl Burgess

Summary

Affiliation: Center for Dermatology and Dermatologic Surgery
Country: USA

Publications

  1. ncbi request reprint Topical vitamins
    Cheryl Burgess
    The Center for Dermatology and Dermatologic Surgery, Washington, DC, USA
    J Drugs Dermatol 7:s2-6. 2008
  2. ncbi request reprint The evolution of injectable poly-L-lactic acid from the correction of HIV-related facial lipoatrophy to aging-related facial contour deficiencies
    Cheryl Burgess
    Center for Dermatology and Dermatologic Surgery, Washington, DC 20037, USA
    J Drugs Dermatol 10:1001-6. 2011
  3. ncbi request reprint Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy
    Cheryl M Burgess
    Center for Dermatology and Dermatologic Surgery, Washington, DC 20037, USA
    J Am Acad Dermatol 52:233-9. 2005
  4. ncbi request reprint Soft tissue augmentation in skin of color: market growth, available fillers, and successful techniques
    Cheryl M Burgess
    Center for Dermatology and Dermatologic Surgery, Washington, DC 20037, USA
    J Drugs Dermatol 6:51-5. 2007
  5. pmc Principles of soft tissue augmentation for the aging face
    Cheryl M Burgess
    Center for Dermatology and Dermatologic Surgery, 2311 M Street, Northwest, Suite 504, Washington, DC 20037, USA
    Clin Interv Aging 1:349-55. 2006
  6. doi request reprint Treatment of facial asymmetry with poly-L-lactic Acid: a case study
    C M Burgess
    Center for Dermatology and Dermatologic Surgery, 2311 M Street, Suite 504, Washington, DC 20037, USA
    Aesthetic Plast Surg 32:552-4. 2008
  7. ncbi request reprint NewFill for skin augmentation: a new filler or failure?
    Cheryl M Burgess
    Dermatol Surg 32:1530-2; author reply 1532. 2006
  8. ncbi request reprint Postinflammatory hyperpigmentation: evolving combination treatment strategies
    Susan C Taylor
    Skin of Color Center, St Luke s Roosevelt Hospital Center, New York, New York, USA
    Cutis 78:6-19. 2006

Detail Information

Publications8

  1. ncbi request reprint Topical vitamins
    Cheryl Burgess
    The Center for Dermatology and Dermatologic Surgery, Washington, DC, USA
    J Drugs Dermatol 7:s2-6. 2008
    ..There is emerging evidence that combinations of vitamins have additive effects that provide enhanced efficacy compared with individual compounds...
  2. ncbi request reprint The evolution of injectable poly-L-lactic acid from the correction of HIV-related facial lipoatrophy to aging-related facial contour deficiencies
    Cheryl Burgess
    Center for Dermatology and Dermatologic Surgery, Washington, DC 20037, USA
    J Drugs Dermatol 10:1001-6. 2011
    ..Understanding differences in the use of injectable PLLA between patients with HIV and those with aging-related facial changes will help physicians optimize patient treatment...
  3. ncbi request reprint Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy
    Cheryl M Burgess
    Center for Dermatology and Dermatologic Surgery, Washington, DC 20037, USA
    J Am Acad Dermatol 52:233-9. 2005
    ....
  4. ncbi request reprint Soft tissue augmentation in skin of color: market growth, available fillers, and successful techniques
    Cheryl M Burgess
    Center for Dermatology and Dermatologic Surgery, Washington, DC 20037, USA
    J Drugs Dermatol 6:51-5. 2007
    ..In addition, soft tissue augmentation strategies and injection techniques that are specific to skin of color are discussed...
  5. pmc Principles of soft tissue augmentation for the aging face
    Cheryl M Burgess
    Center for Dermatology and Dermatologic Surgery, 2311 M Street, Northwest, Suite 504, Washington, DC 20037, USA
    Clin Interv Aging 1:349-55. 2006
    ..This manuscript provides an overview of soft tissue fillers and their proper use...
  6. doi request reprint Treatment of facial asymmetry with poly-L-lactic Acid: a case study
    C M Burgess
    Center for Dermatology and Dermatologic Surgery, 2311 M Street, Suite 504, Washington, DC 20037, USA
    Aesthetic Plast Surg 32:552-4. 2008
    ..The author concludes that injectable PLLA is a safe and effective minimally invasive treatment for facial contour defects...
  7. ncbi request reprint NewFill for skin augmentation: a new filler or failure?
    Cheryl M Burgess
    Dermatol Surg 32:1530-2; author reply 1532. 2006
  8. ncbi request reprint Postinflammatory hyperpigmentation: evolving combination treatment strategies
    Susan C Taylor
    Skin of Color Center, St Luke s Roosevelt Hospital Center, New York, New York, USA
    Cutis 78:6-19. 2006
    ..3%; mequinol 2%-tretinoin (RA) 0.01%; and fluocinolone acetonide (FA) 0.01%, HQ 4%, and RA 0.05%. Recent findings have suggested that mequinol 2%-RA 0.01% solution is a promising alternative for the treatment of PIH...